Subject Index
A
A431 250
aberrations, chromosomal
numerical 67, 81
accessibility of probe 188
age 74,77
alcohol, polyvinyl 227
alkaline
- elution method 4
- hydrolysis 117, 121,224
- phosphatase (ALP)
- - ALP-conjugated antibody
191
- - anti-digoxigenin antibody
conjugated with alkaline
phosphatase 201
3-aminopropyltriehoxysilane 184
ammonium 110
amniocentesis 66
amplifications 66, 81, 83, 96
- ofbiotinized probe fluorescence
80
- catalyzed signal amplification
(SCA) 61
- of oncogenes 67
aneusomy 67
animal embryos 222
antibody reaction, whole mount in
situ hybridization for mRNA
231
anticapillary forceps 35
antifade 72
anti-T-T mouse IgG 131
AP-anti-Dig, whole mount in situ
hybridization for mRNA 231
apoptosis/apoptotic 3, 10, 17, 19
- bodies 39
- cell death 19,31
arthritis, rheumatoid 112
auto fluorescent 45
autoradiography 110, 115
- RNA 123
B
biology, developmental 112
biotin
- biotin-ll - dUTP 5
- - ss cDNA probe 140
- biotin-16-dUTP 23
- digoxigenin 183
- streptavidin-biotin-horseradish
peroxidase 208
- TdT-mediated dUTP-biotin nick
end labeling 35
- transferase-mediated dUTPbiotin nick end labeling
(see TUNEL) 19
biotinylated
- synthesized oligonucleotide
probes 204
- tyramine 60
blocking
- reaction 231
- solution 157, 159
- - digoxigenin 173, 174
blood lymphocytes, peripheral
human (PBL) 4, 6, 7
bone marrow transplantation 67
C
cAMP (cyclic adenosine
3',5'-monophosphate) 242
- response element (eRE) 242
cancer, colorectal 17